A customer uses an automated teller machine (ATM) at a branch of the Truist Bank in Dallas, Texas, U.S., Friday, April 14, 2023.
Shelby Tauber | Bloomberg | Getty Images
The healthcare industry has evolved rapidly over the past decade with the rise of digital services, offering a range of investment opportunities.
TipRanks recognized the top 10 Wall Street analysts in the space to identify the best investment opportunities. These analysts have outperformed their peers with their stock selection and generated outstanding returns with their recommendations.
TipRanks leveraged its expert center tool to recognize those who have a high success rate. We also analyzed every action recommendation made by healthcare analysts over the past decade.
The ranking shows the ability of analysts to deliver returns from their recommendations. TipRanks’ algorithms calculated the statistical significance of each rating, the average return, and the overall analyst hit rate. In addition, each rating was measured over one year.
Top 10 Healthcare Industry Analysts
The image shows the top performing Wall Street analysts in the healthcare sector, in descending order.
1. Thomas Smith – SVB Securities
Thomas Smith tops the list. Smith has an overall success rate of 51%. His highest rating was on Viking therapy (NASDAQ:VKTX), a clinical-stage biopharmaceutical company specializing in therapies for metabolic and endocrine disorders. Its call to buy VKTX shares from April 27, 2022 to April 27, 2023 generated an outstanding return of 791.30%.
2. Brandon Couillard – Jefferies
Brandon Couillard is second on this list and has a success rate of 68%. Couillard’s main recommendation is Exact Sciences (NASDAQ: EXAS), a provider of cancer screening and diagnostic tests. The analyst generated a 450% profit on his buy recommendation on Exact Sciences stock from May 4, 2016 to May 4, 2017.
3. David Windley – Jefferies
Jefferies analyst David Windley ranks No. 3 on the list. Windley has a success rate of 68%. His top recommendation was on Medidata Solutions, a technology company with clinical expertise. Dassault Systèmes then acquired Medidata. The analyst generated a 175.70% reversal from a buy recommendation on MDSO from August 1, 2012 to August 1, 2013.
4. John Eade – Argus Research
John Eade takes fourth place on the list. The five-star analyst has an overall success rate of 69%. Eade’s best recommendation was on Modern (NASDAQ:ARNM), a pharmaceutical and biotechnology company. Its call on MRNA shares generated a return of 265.90% from June 30, 2020 to June 30, 2021.
5. Michael Wiederhorn – Oppenheimer
Michael Wiederhorn, fifth analyst, has a success rate of 66%. His best recommendation is Community health systems (NYSE: CYH), a company active in the management and operation of hospitals. The analyst posted a profit on this stock of 298.2% from May 1, 2020 to May 1, 2021.
6. Charles Duncan – Cantor Fitzgerald
Charles Duncan is in sixth place. The analyst has a success rate of 52%. His main recommendation was Novavax (NASDAQ: NVAX), a biotechnology company that develops vaccines. Thanks to its call to buy NVAX shares, Duncan generated a solid return of 800% from March 17, 2020 to March 17, 2021.
7. Yaron Werber – TD Cowen
Yaron Werber, analyst at TD Cowen, is seventh on this list, with a success rate of 65%. Werber’s best call was a purchase on the shares of Pharmaceutical Ultragenyx (NASDAQ: RARE), a biopharmaceutical company specializing in the development of innovative drugs for rare and ultra-rare diseases. The recommendation generated a return of 267.50% from December 18, 2019 to December 18, 2020.
8. Geulah Livshits – Chardan Capital
In eighth position is Geulah Livshits of Chardan Capital. Livshits has an overall success rate of 42%. The analyst’s main recommendation is Organic cabalette (NASDAQ:CABA), a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Based on his buy call on CABA, the analyst has generated a profit of 800% from October 11, 2022 to present.
9. Richard Newitter-Truist Financial
Richard Newitter ranks ninth on the list. The five-star analyst has a success rate of 62%. His main recommendation was on Organogenesis (NASDAQ: ORGO), a regenerative medicine company providing products for advanced wound care and surgical biologics. The Buy recommendation generated a return of 397.9% from May 12, 2020 to May 12, 2021.
10. Boris Peaker – TD Cowen
Boris Peaker ranks 10th on the list, with a success rate of 47%. Peaker’s best call was a stock purchase of Trillium Therapeutics, a clinical-stage company developing therapies for the treatment of cancer. Pfizer (NYSE: PFE) later acquired Trillium. The recommendation generated a return of 800% from January 7, 2020 to January 7, 2021.
Conclusion
Investors could follow the recommendations of top analysts to make an informed investment decision. You can also view all analysts who made it to the Top 100 list. We will come back soon with the top 10 analysts of the last 10 years in the Consumer Goods sector.
[colabot2]
Source link